Amanta Healthcare Ltd (AMANTA) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 10039743, "name": "Amanta Healthcar", "stock_name": "Amanta Healthcar", "full_name": "Amanta Healthcare Ltd", "name_url": "stocks-analysis/amanta-healthcar", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "100.30", "chg": 0.35, "chgp": "0.35%", "dir": 1, "prev_price": "99.95", "mcapval": "389.00 Cr", "mcap": "Micro Cap", "scripcode": 544502, "symbol": "AMANTA", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "", "isin": "INE084K01015", "curr_date": "Mar 05", "curr_time": "", "bse_nse_vol": "54.66 k", "exc_status": "Active", "traded_date": "Mar 05, 2026", "traded_date_str": "2026 03 05", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-registerF-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/amanta-healthcar-10039743-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0 } }, "news": { "results": [ { "title": "Amanta Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-sell-3855291", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmantaHealthcar_mojoScore_3855291.png", "date": "2026-02-25 10:10:04", "description": "Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amanta Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-sell-3839167", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmantaHealthcar_mojoScore_3839167.png", "date": "2026-02-14 10:10:05", "description": "Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 February 2026, providing investors with the latest insights into the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amanta Healthcare Gains 0.67%: 2 Key Factors Driving This Week’s Move", "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-gains-067-2-key-factors-driving-this-weeks-move-3838822", "imagepath": "", "date": "2026-02-14 09:00:09", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Feb 9:</strong> Stock opens at Rs.106.15, gaining 2.12% on strong volume</p>\n <p><strong>Feb 10:</strong> Q3 FY26 results reveal profit surge amid margin pressures</p>\n <p><strong>Feb 11:</strong> Positive financial trend reported; stock hits intraweek high of Rs.109.05</p>\n <p><strong>Feb 12-13:</strong> Profit-taking leads to declines; week closes at Rs.104.65</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.103.95</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week..." }, { "title": "Are Amanta Healthcare Ltd latest results good or bad?", "link": "https://www.marketsmojo.com/news/result-analysis/are-amanta-healthcare-ltd-latest-results-good-or-bad-3833639", "imagepath": "", "date": "2026-02-11 19:56:26", "description": "Amanta Healthcare Ltd's financial results for the quarter ending December 2025 present a mixed picture. The company reported a net profit of ₹4.63 crores, which reflects a significant quarter-on-quarter increase of 282.64%. This surge in profit is primarily attributed to a reduction in interest costs and improved tax efficiency rather than operational improvements. Revenue for the quarter stood at ₹74.49 crores, indicating a sequential growth of 5.08% from the previous quarter and a year-on-year increase of 9.85%.\n\nHowever, the operating margin has contracted, decreasing by 159 basis points to 20.62% compared to the same quarter last year. This decline in margins suggests that the company is facing challenges related to rising input costs and competitive pricing pressures within the pharmaceutical sector. The profit after tax margin improved to 6.22% from a lower figure in the previous quarter, yet it remai..." }, { "title": "Amanta Healthcare Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend", "link": "https://www.marketsmojo.com/news/stocks-in-action/amanta-healthcare-ltd-reports-strong-quarterly-upswing-amid-positive-financial-trend-3832215", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmantaHealthcar_fintrenddot_3832215.png", "date": "2026-02-11 08:00:52", "description": "Amanta Healthcare Ltd has demonstrated a notable turnaround in its financial performance for the quarter ended December 2025, shifting from a flat to a positive growth trajectory. This improvement is reflected in key metrics such as revenue, profitability, and operating efficiency, signalling a potential stabilisation in the company’s business fundamentals despite broader market headwinds." }, { "title": "Amanta Healthcare Q3 FY26: Profit Surge Masks Underlying Margin Pressures", "link": "https://www.marketsmojo.com/news/result-analysis/amanta-healthcare-q3-fy26-profit-surge-masks-underlying-margin-pressures-3831666", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmantaHealthcar_quaterlyResult_3831666.png", "date": "2026-02-10 17:49:32", "description": "Amanta Healthcare Ltd. reported a robust 282.64% quarter-on-quarter surge in net profit for Q3 FY26, reaching ₹4.63 crores compared to ₹1.21 crores in Q2 FY26, whilst also posting a modest 8.15% year-on-year growth from ₹4.28 crores in Q3 FY25. The micro-cap pharmaceutical company, with a market capitalisation of ₹413 crores, saw its stock trade at ₹107.75 on February 10, 2026, up 1.51% from the previous close. However, beneath the headline profit growth lies a complex narrative of margin compression and operational challenges that warrant closer scrutiny from investors." }, { "title": "Amanta Healthcare Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcare-ltd-is-rated-sell-3817783", "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/AmantaHealthcar_mojoScore_3817783.png", "date": "2026-02-03 10:14:03", "description": "Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amanta Healthcar is Rated Sell by MarketsMOJO", "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcar-is-rated-sell-by-marketsmojo-3801423", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AmantaHealthcar_mojoScore_3801423.png", "date": "2026-01-23 10:10:54", "description": "Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook." }, { "title": "Amanta Healthcar is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/amanta-healthcar-is-rated-sell-3789744", "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/AmantaHealthcar_mojoScore_3789744.png", "date": "2026-01-12 10:10:21", "description": "Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook." } ], "total": 12, "sid": "10039743", "stock_news_url": "https://www.marketsmojo.com/news/amanta-healthcare-10039743" }, "announcements": [ { "caption": "Open Market Purchase Of Equity Shares By Promoter", "datetime": "27-Feb-2026", "details": "We would like to inform you that we have received disclosure in Form C pursuant to Regulation 7(2) of the SEBI (PIT) REGULATION 2015 from the Promoter.", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Credit Rating", "datetime": "16-Feb-2026", "details": "Announcement under Regulation 30 (LODR) - Credit Rating", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript", "datetime": "16-Feb-2026", "details": "Announcement under Regulation 30 (LODR) - Earnings Call Transcript", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "No <strong>Dividend</strong> history available", "data": [] }, { "img": "splits.svg", "title": "SPLITS", "msg": "No <strong>Splits</strong> history available", "data": [] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Feb 9: Stock opens at Rs.106.15, gaining 2.12% on strong volume

Feb 10: Q3 FY26 results reveal profit surge amid margin pressures

Feb 11: Positive financial trend reported; stock hits intraweek high of Rs.109.05

Feb 12-13: Profit-taking leads to declines; week closes at Rs.104.65

Week Open

Rs.103.95

Week...

Read full news article

Are Amanta Healthcare Ltd latest results good or bad?

2026-02-11 19:56:26

Amanta Healthcare Ltd's financial results for the quarter ending December 2025 present a mixed picture. The company reported a net profit of ₹4.63 crores, which reflects a significant quarter-on-quarter increase of 282.64%. This surge in profit is primarily attributed to a reduction in interest costs and improved tax efficiency rather than operational improvements. Revenue for the quarter stood at ₹74.49 crores, indicating a sequential growth of 5.08% from the previous quarter and a year-on-year increase of 9.85%. However, the operating margin has contracted, decreasing by 159 basis points to 20.62% compared to the same quarter last year. This decline in margins suggests that the company is facing challenges related to rising input costs and competitive pricing pressures within the pharmaceutical sector. The profit after tax margin improved to 6.22% from a lower figure in the previous quarter, yet it remai...

Read full news article

Amanta Healthcare Ltd Reports Strong Quarterly Upswing Amid Positive Financial Trend

2026-02-11 08:00:52

Amanta Healthcare Ltd has demonstrated a notable turnaround in its financial performance for the quarter ended December 2025, shifting from a flat to a positive growth trajectory. This improvement is reflected in key metrics such as revenue, profitability, and operating efficiency, signalling a potential stabilisation in the company’s business fundamentals despite broader market headwinds.

Read full news article

Amanta Healthcare Q3 FY26: Profit Surge Masks Underlying Margin Pressures

2026-02-10 17:49:32

Amanta Healthcare Ltd. reported a robust 282.64% quarter-on-quarter surge in net profit for Q3 FY26, reaching ₹4.63 crores compared to ₹1.21 crores in Q2 FY26, whilst also posting a modest 8.15% year-on-year growth from ₹4.28 crores in Q3 FY25. The micro-cap pharmaceutical company, with a market capitalisation of ₹413 crores, saw its stock trade at ₹107.75 on February 10, 2026, up 1.51% from the previous close. However, beneath the headline profit growth lies a complex narrative of margin compression and operational challenges that warrant closer scrutiny from investors.

Read full news article

Amanta Healthcare Ltd is Rated Sell

2026-02-03 10:14:03

Amanta Healthcare Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 February 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell by MarketsMOJO

2026-01-23 10:10:54

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics presented here reflect the stock's current position as of 23 January 2026, providing investors with an up-to-date view of the company's fundamentals, valuation, financial trends, and technical outlook.

Read full news article

Amanta Healthcar is Rated Sell

2026-01-12 10:10:21

Amanta Healthcar is rated 'Sell' by MarketsMOJO, with this rating last updated on 22 December 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 12 January 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Read full news article